Send the following on WhatsApp
Continue to ChatMerck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational Intent https://www.businessline.global/merck-advances-atr-inhibitor-berzosertib-in-small-cell-lung-cancer-with-new-published-data-and-initiation-of-phase-ii-trial-with-registrational-intent/press-release/